Navigation Links
BioElectronics Announces Major Clinical Trials
Date:5/28/2008

Breast augmentation and cesarean section trials in conjunction with David

G. Genecov, MD, FACS, FAAP to begin immediately

FREDERICK, Md., May 28 /PRNewswire-FirstCall/ -- BioElectronics Corp. (Pink Sheets: BIEL), the maker of the ActiPatch(TM), a drug free anti- inflammatory patch, with an embedded battery operated microchip delivering continuous pulse therapy specifically designed to speed healing, today announced world renowned plastic surgeon David G. Genecov will develop, institute and complete research studies on post-operative management of breast augmentation and cesarean section procedures. Both double blind randomized studies will be done in conjunction with other leading surgeons, obstetricians and gynecologists under Dr. Genecov's direction and supervision.

"We are very excited about these studies and believe they mark an important turning point for BioElectronics Corporation. The use of our products for post-breast augmentation care is already well established and continues to grow at a rapid pace," commented, Andy Whelan, CEO and President of BioElectronics Corporation. "The completion of a formal study by a surgeon of Dr. Genecov's caliber will further cement our position in this important and growing area. We are also very excited to be starting the trial for post- operative care for cesarean section. According to the National Center for Health Statistics, approximately one third of all babies in the United States are delivered by cesarean section up from less than approximately 20% just a decade ago. We believe this growing market represents a substantial market opportunity for our company."

Dr. David G. Genecov added, "Many general and plastic surgeons are starting to investigate the use of ActiPatch for post-surgical edema and pain control, but there has been little clinical data. We look forward to providing this important data to our colleagues over the coming months in order to determine the best post-ope
'/>"/>

SOURCE BioElectronics Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
2. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
3. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
4. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
5. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
6. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
7. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
8. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
9. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
10. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
11. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, ... OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE ... JURISDICTION AbbVie (NYSE: ABBV ) today announced financial ... "This was another very strong quarter for AbbVie, ... original guidance and announced plans to merge with Shire, a ...
(Date:7/24/2014)... OVERLAND PARK, Kan. , July 24, 2014 ... licensing of two compounds that will be added ... agreement with Australian-based CIMTECH Pty Ltd, a biotechnology ... and PAR 122 have shown promise in bone ... a license to develop the compounds for the ...
(Date:7/24/2014)... , and MARSEILLE, France , July ... Exclusive global license from University of Tokyo enables development ... (NGS) gene panels, for blood cancers  Mutations ... indicate favorable prognosis for patients with bone marrow disorders ... for developing companion diagnostics to guide treatment with new ...
Breaking Medicine Technology:AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32AbbVie Reports Second-Quarter 2014 Financial Results 33AbbVie Reports Second-Quarter 2014 Financial Results 34AbbVie Reports Second-Quarter 2014 Financial Results 35AbbVie Reports Second-Quarter 2014 Financial Results 36
... 9 Pharmacyclics, Inc.,(Nasdaq: PCYC ) today ... orally available, selective inhibitor of Bruton,s tyrosine,kinase, or ... model,for rheumatoid arthritis (RA). The data were presented ... being held this,week in Boston, MA., Researchers ...
... shows, investigational regimen resulted in 82 percent overall survival and 78 ... ... is presently being conducted in this ... patient population, LUGANO, Switzerland, June 9 In an ...
Cached Medicine Technology:Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 2Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 3Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 4Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 2Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 3Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 4
(Date:7/25/2014)... 2014 Sport Court® provided ... Nike National Invitational Tournament (NIT) in Chicago ... Junior National Tournament (USJN) in Washington D.C. at ... for these prestigious national tournaments included 44 Sport Court ... of playing surface at McCormick Place for the NIT, ...
(Date:7/25/2014)... As reported by Wood TV 8 in the article ... seen a nearly 500-person increase in heroin related overdose deaths ... between 1999 and 2002, the toll increased to 728 during ... states, drug users in Michigan have turned to heroin after ... the price of both substances, noting that an 80-milligram pill ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Reproductive Science ... announce that Dr. Kerri Luzzo, Lead Physician at RSC ... for her professional accomplishments in fertility care and community ... At the 10th Annual PBN Awards ceremony held July ... 40 of the most highly regarded, emerging leaders in ...
(Date:7/25/2014)... 25, 2014 As reported by People Magazine ... After Jersey Shore and Getting Sober (7/15), one of ... Shore, has spoken out to the public about his personal ... show, The Situation admits that moving on with his life ... drugs, and other drugs in 2012 and even spent some ...
(Date:7/25/2014)... Florida Hospital and MOSI officially announced a transformational partnership ... come and make a difference in the Tampa Bay community. ... to provide the support needed to keep the science center ... the IMAX Dome Theatre from film to a state-of-the-art digital ... Theatre in the state of Florida, and it is one ...
Breaking Medicine News(10 mins):Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4
... and ... Children,s Hospital Boston, BOSTON, April 8, 2008 Hess ... help support,children with medical needs through the Jimmy Fund and the ... every home run hit during a New,England Sports Network (NESN) televised ...
... Building Innovations, Products Help Protect and Preserve Buildings, ... DuPont (NYSE:,DD) and The Energy and Resources Institute ... the cause of green building design and,certification in ... Kalsi, president of DuPont India,and Dr. R. K. ...
... Distort State Funding, HARRISBURG, Pa., April 8, ... by more than $500 million in the past ... today expressed,continuing concern about misleading claims from nursing ... Pennsylvania,s nursing,home facilities., "Nursing home representatives seem ...
... PITTSBURGH, April 8, 2008 Precision Therapeutics ... it signed contracts with,National Preferred Provider Network ... NPPN, headquartered in Middletown, NY, is ... country representing more than seven million lives. ...
... at Events Nationwide Saturday, April 12, to Help ... 8, 2008 On Saturday, April 12, more than,600,000 ... Healthy,Kids(R) Day -- the nation,s largest health day for ... YMCA Healthy Kids Day encourages families,to "Put Play in ...
... Auctions off Flight Simulator Experience on eBay, ... one lucky guest in the captain,s seat in ... Cancer Society (ACS), United is auctioning off a,behind-the-scenes ... Flight Training Center in Denver, Colo., including two ...
Cached Medicine News:Health News:Every Boston Red Sox Home Run Televised on NESN in 2008 to Help Children With Medical Needs 2Health News:Every Boston Red Sox Home Run Televised on NESN in 2008 to Help Children With Medical Needs 3Health News:DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India 2Health News:DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India 3Health News:DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India 4Health News:Precision Therapeutics Adds 8 Million Covered Lives Under Contract 2Health News:YMCA of the USA Celebrates 'YMCA Healthy Kids(R) Day,' the Nation's Largest Health Day for Children and Families 2Health News:YMCA of the USA Celebrates 'YMCA Healthy Kids(R) Day,' the Nation's Largest Health Day for Children and Families 3Health News:YMCA of the USA Celebrates 'YMCA Healthy Kids(R) Day,' the Nation's Largest Health Day for Children and Families 4Health News:YMCA of the USA Celebrates 'YMCA Healthy Kids(R) Day,' the Nation's Largest Health Day for Children and Families 5Health News:Be in the Captain's Seat in the Fight Against Cancer 2Health News:Be in the Captain's Seat in the Fight Against Cancer 3
The precise, fully reusable R-100 Pullback Device is an invaluable tool during plaque volumetric analysis....
... you perform exams from cardiac to angio. ... no compromises. An ideal 31 centimeters square, ... of cardiovascular and interventional imaging. With a ... variety of vascular and interventional procedures. The ...
... The RX daytona is a fully ... field in bench top analysers offering many ... standing systems. With reusable glass cuvettes, on ... and reagents, the random access analyser can ...
Inquire...
Medicine Products: